ATAI Life Sciences NV at Citi BioPharma Conference Transcript
I'm Neena Bitritto-Garg, and I'm one of the biotech analysts here at Citi. I'm very pleased to be joined for our next company panel where we're going to be focusing on mental health and new kind of innovative options for mental health conditions. I've got with me the new CEO of COMPASS Pathways, Kabir Nath; the Chief Medical Officer of Pear Therapeutics, Yuri Maricich; and Florian Brand, the CEO of Atai Life Sciences.
So before we get into Q&A, I want to pass it to each of you to make some opening remarks. And maybe we'll start with Florian.
Sure, yes. Happy to be here. Thanks for overseeing us. And I think it's a very interesting panel as it combines a range of modalities that we, I think, all are working on, especially with the digital component. And so here is Atai, our biotech -- or biopharmaceutical company in the clinical stage and also heavily believe in the potential of digital
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
